Volume 29, Number 3—March 2023
Research
Postacute Sequelae of SARS-CoV-2 in University Setting
Megan Landry
, Sydney Bornstein, Nitasha Nagaraj, Gary A. Sardon, Amanda Castel, Amita Vyas, Karen McDonnell, Mira Agneshwar, Alyson Wilkinson, and Lynn Goldman
, Sydney Bornstein, Nitasha Nagaraj, Gary A. Sardon, Amanda Castel, Amita Vyas, Karen McDonnell, Mira Agneshwar, Alyson Wilkinson, and Lynn Goldman
Table 1
Initial case investigation and long COVID data collection for postacute sequelae of SARS-CoV-2 in university setting, Washington, DC, USA*
| Characteristic |
Value |
|---|---|
| Positive test results reported during 2020 Aug–2022 Feb | 4,800 |
| GWU PCR | 3,228 |
| External CLIA PCR or self-administered antigen | 1,572 |
| Initial case investigation incomplete | 133 |
| Initial case investigation data missing | 1,072 |
| Total positive test results with case investigation data |
3,595 |
| Long COVID surveys sent out, 2021 Jul–2022 Mar | 4,800 |
| Repeat infection duplicates | 143 |
| Persons surveyed | 4,657 |
| Responses received | 1,493 |
| Duplicate responses/multiple responses | 11 |
| Persons responding | 1,482 |
| Response rate, 1,482/4,657 | 31.8% |
| Responders with incomplete case investigation | 141 |
| Responders with incomplete long COVID questions | 3 |
| Total valid responses | 1,338 |
*Values are no. except as indicated. CLIA, Clinical Laboratory Improvement Amendments; GWU, George Washington University.
Page created: December 15, 2022
Page updated: February 19, 2023
Page reviewed: February 19, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.